Subscribe

Ardenwell Press

Pharmacology of Change

For most of the twentieth century, doctors treated obesity as a behavior problem. The advice followed from that belief: eat less, move more, and if that does not work, try harder. It was one of the longest-running failures in modern medicine. Almost nobody recorded it as a failure, because when the advice stopped working, the patient got blamed instead of the theory.

The theory was wrong.
What replaced it was not a new diet or a new philosophy. It was a molecule.

In the 1980s, scientists studying hormones in the gut found one they named glucagon-like peptide-1, or GLP-1. Your intestine releases it when food arrives. It tells the pancreas to release insulin. It tells the liver to stop pushing stored sugar into the blood. It slows how quickly the stomach empties. And it sends a message to the brain that says, in effect, we are fed.

In the 1980s, scientists studying hormones in the gut found one they named glucagon-like peptide-1, or GLP-1. Your intestine releases it when food arrives. It tells the pancreas to release insulin. It tells the liver to stop pushing stored sugar into the blood. It slows how quickly the stomach empties. And it sends a message to the brain that says, in effect, we are fed.

There was one problem. GLP-1 disappears almost as fast as it appears. It survives about two minutes in the bloodstream before an enzyme called DPP-4 finds it and snips two amino acids off one end, switching it off.

That two-minute lifespan stalled the field for years. You cannot build a medication out of a molecule the body destroys before it finishes talking.

The first way around it came from a lizard. The venom of the Gila monster contains a peptide called exendin-4, which is close enough to human GLP-1 to switch on the same receptor, but shaped differently enough that DPP-4 cannot cut it. That became exenatide, the first drug in the class. It proved the idea worked. It also had to be injected twice a day.

Semaglutide is what happened when chemists went at the problem directly, and they made two changes.

First, DPP-4 grabs GLP-1 at one specific spot near the end of the chain. Chemists swapped the amino acid at that spot for a slightly different one the enzyme cannot get hold of. The cut never happens.

Second, they attached a fatty acid chain to the molecule. That chain lets the drug grip albumin, the most common protein in blood. Albumin functions as a delivery truck. A drug riding on one stays in circulation far longer than a drug traveling alone.

Together, those two changes stretch the half-life from roughly two minutes to roughly a week. Once-weekly dosing is not a marketing decision. It is a consequence of the chemistry.

Then came the finding that reorganized the field.

GLP-1 receptors — the docking points the hormone attaches to — are not only in the pancreas. Some sit in the hypothalamus, in a region called the arcuate nucleus, where the brain tracks the body’s energy supply. Others sit in parts of the brainstem where the barrier that normally shields the brain is deliberately left open so it can read what is circulating in the blood.

When a long-acting drug reaches those neurons, it does what the natural hormone does, except it does not stop after two minutes. It turns up the feeling of fullness and turns down the drive to eat. In the STEP 1 trial, adults taking semaglutide 2.4 mg lost about 15 percent of their body weight over 68 weeks. Tirzepatide, which activates a second gut-hormone receptor called GIP as well, produced about 21 percent in the SURMOUNT-1 trial.

Read those numbers carefully. They do not show that a better drug finally supplied the willpower patients were missing. They show that hunger was never a matter of character. Hunger is a signal. It has a receptor, and it responds to a dose. Anything that can be measured that precisely can be treated.

But it can only be treated while the drug is present.

This next part gets the least attention and decides the most outcomes.

Your body defends a weight. Lose fat by any method and three things happen at once. Leptin falls, so the brain reads your energy reserves as running low. Ghrelin rises, so you get hungrier. And your body begins burning fewer calories at rest than its new size would predict.

That defense does not shut off because the weight came off with a medication. A GLP-1 drug does not repair the thermostat. It holds a finger on the dial. Take the drug away and the finger lifts. In the follow-up phase of STEP 1, people who stopped the medication regained about two-thirds of the weight they had lost within a year.

That is not the patient failing, and it is not the drug failing. It is a system doing exactly what it evolved to do.

There is a second limit, quieter and more consequential.

The drug controls appetite. It does not decide what you eat, and it does not build muscle. Losing weight quickly, by any method, costs you lean tissue along with fat. Lean tissue is muscle and organ mass. It sets how many calories you burn at rest, how well your body handles blood sugar, and whether you can still carry your own groceries at eighty.

So a patient can follow every instruction and still finish treatment lighter, weaker, and more likely to regain than when they started. The drug answered the question it was built to answer. Nobody answered the rest.

That is what we mean by the pharmacology of change.

The chemistry did change, and it changed in earnest. Fifty years of moral instruction was displaced in about fifteen years by a receptor, a modified peptide, and a fatty acid tail. But the change was always going to be partial. Medication changed the biology of hunger. It did not change the biology of what happens to a body while it is losing weight, or after.

That gap is where patients are standing right now, usually on their own.

The questions worth asking are not complicated. What is this drug doing inside me? Which of my results come from the medication, and which come from what I do while I am taking it? How much of what I am losing is fat, and how much is muscle? What is the plan for the day the prescription ends?

None of that requires a pharmacy degree to understand. It requires only that somebody take the time to answer it properly.

Anyone who picks up one of these prescriptions deserves more than the leaflet stapled to the bag.

The four terms, defined
GLP-1 (glucagon-like peptide-1) — A hormone your intestine releases when you eat. It works like a messenger announcing that a meal has arrived: it tells the pancreas to release insulin, tells the liver to stop releasing stored sugar, slows how fast the stomach empties, and signals the brain that you are fed. Drugs like semaglutide and tirzepatide are long-lasting copies of this messenger.
DPP-4 (dipeptidyl peptidase-4) — An enzyme circulating in your blood whose job is to shut GLP-1 off. It finds the hormone and snips two amino acids off one end, which deactivates it. This happens within about two minutes, and it is the reason natural GLP-1 could never be used as a drug on its own.
Leptin — A hormone released by your fat cells. It reports to the brain how much energy you have stored, like a fuel gauge. When you lose fat, leptin falls, and the brain reads that drop as a warning that reserves are running low.
Ghrelin — A hormone released mainly by your stomach when it is empty. It rises before meals and triggers hunger — the dinner bell. When you lose weight, ghrelin climbs and stays elevated.

Leptin and ghrelin pull in opposite directions, and after weight loss both shift toward the same outcome: eat more.

The four terms, defined

GLP-1 (glucagon-like peptide-1) — A hormone your intestine releases when you eat. It works like a messenger announcing that a meal has arrived: it tells the pancreas to release insulin, tells the liver to stop releasing stored sugar, slows how fast the stomach empties, and signals the brain that you are fed. Drugs like semaglutide and tirzepatide are long-lasting copies of this messenger.
DPP-4 (dipeptidyl peptidase-4) — An enzyme circulating in your blood whose job is to shut GLP-1 off. It finds the hormone and snips two amino acids off one end, which deactivates it. This happens within about two minutes, and it is the reason natural GLP-1 could never be used as a drug on its own.
Leptin — A hormone released by your fat cells. It reports to the brain how much energy you have stored, like a fuel gauge. When you lose fat, leptin falls, and the brain reads that drop as a warning that reserves are running low.
Ghrelin — A hormone released mainly by your stomach when it is empty. It rises before meals and triggers hunger — the dinner bell. When you lose weight, ghrelin climbs and stays elevated.

Leptin and ghrelin pull in opposite directions, and after weight loss both shift toward the same outcome: eat more.